Skip to main content

Table 1 Clinical symptoms (days with symptoms) evaluated in Group A and in Group B at T1, T2, and T3

From: Resveratrol plus carboxymethyl-β-glucan in children with recurrent respiratory infections: a preliminary and real-life experience

Symptoms Group A P value Group B P value
  T1 T2 T3   T1 T2 T3  
Nasal obstruction 3.3 ± 1.7 6 ± 4.4 8.3 ± 5.2 < 0.001 3.7 ± 1.7 1.2 ± 1.4 1.6 ± 2.2 < 0.001
Rhinorrhea 5 ± 1.5 8.5 ± 6.1 12.1 ± 5.7 < 0.001 4.7 ± 1.6 3 ± 2.9 2.8 ± 3 < 0.001
Sneezing 0.7 ± 1 1.6 ± 2.3 1.3 ± 1.7 < 0.001 0.8 ± 1.3 0.3 ± 1.1 0.3 ± 1.1 < 0.001
Cough 3.5 ± 3.3 3.5 ± 3 3.6 ± 3.2 N.S. 3.5 ± 3.2 1.9 ± 2.7 2.2 ± 3.1 0.002
Fever 1.5 ± 1.7 1.2 ± 2.5 1.2 ± 1.5 N.S. 0.3 ± 0.7 1.8 ± 2.4 0.2 ± 0.5 <0.001
Medications 9.3 ± 0.7 5.5 ± 3 5.9 ± 2.8 <0.05 9.1 ± 0.6 1.3 ± 1.8 2.5 ± 2.9 <0.001
Medical visits 0.5 ± 0.7 1.5 ± 1 1.5 ± 1.2 <0.001 0.4 ± 0.6 0.6 ± 0.9 0.8 ± 1.4 <0.001
Absences at school 1.4 ± 2 2.3 ± 2.1 2.3 ± 2 <0.005 0.4 ± 0.7 1 ± 1 1.3 ± 1.8 <0.001